Familial hypercholesterolemia is an inherited disease in humans that is caused by a defect in the receptor for low density lipoproteins (LDLR). The existence of an animal model for this disease, the Watanabe heritable hyperlipidemic (WHHL) rabbit, makes it an attractive candidate for developing new therapies that involve gene transfer into liver. As a first step toward the development of these therapies, we report the use of retrovirus-mediated gene transfer to correct the genetic defect in hepatocytes isolated from WHHL rabbits. A series of retroviral vectors that express the gene for human LDLR were constructed, each differing in the transcriptional elements used to drive LDLR expression. Helper-free amphotropic virus stocks representing each construct were then used to infect primary cultures of hepatocytes that were isolated from newborn WHHL rabbits. The efficiency of transduction, as measured by Southern analysis of integrated proviral sequences, ranged from 20% to 100%. Expression of human LDLR was analyzed by blot hybridization analysis of total cellular RNA and by biochemical and in situ analyses of transduced cultures for receptor function. The vector in which the expression of LDLR was driven by the viral long terminal repeat sequence produced the greatest quantity of LDLR RNA and protein in
New therapies that involve the transfer of normal genetic material into genetically abnormal tissue are being considered in the treatment of several inherited diseases. Previously, most attention has been placed on diseases treatable by gene transfer into bone marrow, such as the severe-combined immunodeficiency syndromes (1) and thalassemias (2) . However, recent advances in hepatocyte transplantation (3) and the demonstration of efficient gene transfer into cultured hepatocytes (4) (5) (6) suggest that new therapeutic approaches based on gene transfer may also be possible for the treatment of inherited diseases that have their origin in the liver.
One such disease, familial hypercholesterolemia, is an autosomal dominant disorder in humans that leads to elevated levels of serum cholesterol and the premature development of coronary artery disease (reviewed in ref. 7) . The primary genetic defect in this disorder is an abnormality in the expression or function of the receptor for low density lipoproteins (LDLR). Patients with two abnormal alleles for LDLR have severe hypercholesterolemia that is refractory to conventional medical therapy; they often die of myocardial infarction before the age of 20 (7) . Liver transplantation has been performed in several receptor-negative patients and has successfully corrected the deleterious metabolic consequences of the primary receptor deficiency state (8) . However, the relatively high morbidity and mortality of this surgical procedure along with the requirement for life-long immunosuppressive therapy restrict the use of this therapeutic approach to a very limited patient population.
In 1973, Watanabe (9) . The WHHL rabbit was subsequently shown to be deficient in functional LDLR activity due to an in-frame deletion of a portion of the LDLR structural gene (10) . This animal model was instrumental in delineating key steps in the regulation of cholesterol metabolism in vivo (reviewed in ref. 11 ). The existence of such an animal model for an important inherited disease of the liver has prompted us to investigate the feasibility of developing a genetic therapy for familial hypercholesterolemia. As a first step, we describe here the successful use of retrovirusmediated gene transfer to correct the genetic defect in hepatocytes from WHHL rabbits.
METHODS
Isolation, Maintenance, and Infection of Hepatocytes. Newborn New Zealand White (NZW) rabbits and WHHL rabbits (3-5 days old, weighing 50-80 g) were used as the source of hepatocytes. Newborn WHHL rabbits were derived from matings between homozygous deficient males and females and were kindly provided by J. Knapka (National Institutes of Health). Four WHHL rabbits from two litters (two rabbits per litter) were used in these studies (named WHHL 1-4). Newborn NZW rabbits purchased from Pine Acres Rabbitry (West Brattleboro, VT) were used as controls. Hepatocytes from newborn rabbits were prepared as described for adult rats (6) except the collagenase perfusions were performed retrograde (12) . Cells were plated at a density of 3-4 x 104 cells per cm2 onto plates with a polycationic matrix (Primaria; Falcon, Oxnard, CA) in hormonally defined medium (13) supplemented with 10% fetal bovine serum; 4-6 hr later the medium was replaced with fresh hormonally defined medium, which was subsequently changed every 24 hr during the duration of the experiment.
Hepatocyte cultures were infected for 12 hr with viral stocks (5 ml per 10-cm plate) containing Polybrene (8 ,ug/ml) . Unconcentrated viral stocks were prepared from the producer cells as described (6) .
DNA and RNA Analyses. DNA and RNA were prepared and analyzed as described (6, 14) . Hybridization filters were probed with a 1.9-kilobase (kb) LDLR cDNA fragment (HindIII to EcoRI fragment of pTZ1) that was labeled to high specific activity with [32P]dCTP by using the random primer method (15) . RNA (25) . Each of the three vectors also contains a deletion of viral transcriptional enhancer sequences located in the 3' LTR, so as to reduce the amount of viral transcription after reverse transcription and integration of the recombinant provirus (26) . Human LDLR coding sequences for all four vectors were derived from a full-length human LDLR cDNA insert.
Virus-producing cell lines were isolated for each vector by using the amphotropic packaging cell line qi-Cript as described (26) . Individual virus-producing clones were tested for production of virus that transmitted the correct proviral structure by Southern analysis as described (6) . Cell lines transmitting the highest number of proviral copies to recipient cells were chosen for this study. All virus-producing cell lines were maintained in culture for 4-6 wk prior to their use in order to test for the presence of helper virus. None of the cell lines yielded any detectable helper virus nor transferred the packaging functions (data not shown).
Transfer and Expression of LDLR in Hepatocytes. Cells used for the infection studies were hepatocytes isolated from three NZW rabbits and four WHHL rabbits (see Methods). (22) . The backbone structure of plasmids BA-LDLR, H4-LDLR, and TK-LDLR (including the 5' LTR, flanking mouse genomic DNA, pBR322 sequences, and 3' LTR with contiguous proviral sequence to the Cla I site at nucleotide 7674) were derived from Dol (20) with the exception that sequences containing the viral enhancer elements of the 3' LTR (from the Prv II site at nucleotide 7933 to the Xba I site at nucleotide 8111) were deleted. These vectors also contained additional Mo-MLV sequence between the 5' LTR and the internal promoters. The additional sequence was derived from wild-type Mo-MLV (from nucleotide 146 at the border of U5 to the Xho I site in the gag-coding region at nucleotide 1560) with the exception that a Sac II linker was inserted at the Hae III site at nucleotide 624. In each case LDLR-coding sequences were derived from a 2.6-kb HindIII fragment of plasmid pTZ1, which contains a full-length LDLR cDNA insert (kindly provided by D. Russell, J. Goldstein, and M. Brown). The HindIII sites were converted to Bcl I sites and the cDNA was cloned into the BamHI site of the vectors. This fragment of PTZ1 contributed 13 base pairs (bp) of 5' untranslated sequence (AGCTTAATACACA) and 5 bp of 3' untranslated sequence (ATCAG) to the transcriptional unit. A more detailed description of the vector constructions will be provided elsewhere (B. C. Guild and R.C.M., unpublished data). SD indicates splice donor site; arrows under each vector show the sites of transcriptional initiation.
To document the cellular composition of the cultures, mock-infected WHHL hepatocytes cultured for 5 days were analyzed in several ways. First, the cells were analyzed for the hepatocyte-specific enzyme glucose-6-phosphatase by using an enzyme cytochemical stain (6) . As shown in Fig. 2b , >95% of the cells had the brown cytoplasmic staining characteristic of hepatocytes. No activity was detected in pure cultures of fibroblasts (Fig. 2c) or endothelial cells (data not shown). In addition, the cultures were analyzed for the presence of endothelial cells and Kupffer cells, since these nonparenchymal cells are abundant in the intact liver and could potentially contaminate the primary cultures. Hepatic endothelial cells (18) as well as Kupffer cells (27) express high levels of the receptor for AcLDL and can be identified in mixed cultures by their selective uptake of Dil-AcLDL. Analysis of cultured hepatocytes for Dil-AcLDL uptake revealed that -1 in 50 cells was fluorescent (Fig. 2e and J) . The Hepatocytes isolated from a NZW rabbit and WHHL rabbit 1 were infected with the LDLR retroviruses and analyzed for the uptake of Dil-LDL. Each panel is a representative fluorescent micrograph ( x 90) of a confluent plate of hepatocytes (as pictured in e): mock-infected hepatocytes from a NZW rabbit (g) and hepatocytes from a WHHL rabbit that were mock-infected (h) or infected with the BA-LDLR virus (i), the H4-LDLR virus (j), the TK-LDLR virus (k), or the LTR-LDLR virus (1).
cultures was equivalent to that seen in pure secondary cultures of endothelial cells derived from bovine aorta (Fig. 2d) .
To optimize the conditions for infection ofthe hepatocytes, we utilized a high-titer amphotropic virus (BAG) encoding Escherichia coliB-galactosidase (28) . Cells transduced by the BAG virus can be detected by a simple cytochemical reaction that stains the cell's cytoplasm blue (28) . Optimal transduction of WHHL hepatocytes was achieved with cells from newborn animals that were plated at subconfluent density and exposed to virus 36 hr after the initial plating (data not shown). The matrix substrata had little effect on transduction efficiency (data not shown). An example of WHHL hepatocytes infected with the BAG virus and analyzed for,-galactosidase expression is shown in Fig. 2a .
Having optimized the conditions for infection, NZW and WHHL hepatocytes were infected with the four different LDLR virus preparations 2 days after being placed in culture and were analyzed for gene transfer and LDLR expression on day 5 . Integration of the recombinant proviral sequences into the cellular DNA isolated from infected hepatocytes was detected by Southern blot analysis (Fig. 3) . DNA lyzed by the method of Southern (29) Additional experiments were performed to show that the viral DNA detected in Fig. 3 was integrated into hepatocyte DNA. DNAs from transduced hepatocytes were digested with EcoRI (a restriction enzyme that has a single site in the proviral DNA) and subjected to Southern analysis using a LDLR probe. If the viral DNA existed as an integrated provirus no distinct EcoRI fragments should be detected because the outer borders of these fragments are located in flanking DNA and therefore are heterogeneous. In fact, no EcoRI fragments were detected when this analysis was done, suggesting that the majority of viral DNA was integrated into hepatocyte chromosomal DNA (data not shown).
Transduced cultures were first analyzed for LDLR expression by blot hybridization analysis of cellular RNA. (Fig. 4) . A faint band with an apparent molecular size equal to 3.5 kb was detected in mock-infected cultures (Fig. 4, lane con) ; this band probably represents endogenous LDLR RNA. The predominant RNA species in cultures infected with BA-LDLR, H4-LDLR, and TK-LDLR were the transcripts initiated at the internal promoter. The relative abundance of these RNAs consistently varied in a vector-dependent manner as follows: BA-LDLR > H4-LDLR > TK-LDLR > putative endogenous signal. As expected, very little transcription initiated from the LTR of these vectors was detected since the enhancer deletion that is present in the 3' LTR of the starting plasmid is transferred to the 5' LTR during proviral passage into hepatocytes (26) . Cultures infected with the LTR-LDLR virus produced a single very intense band representing a transcript initiated at the LTR. All blots were stripped and reprobed with a human y-actin cDNA probe to control for variation in the amount of RNA that was loaded. There was no detectable variation in the intensity of the 'y-actin band, suggesting that equal quantities of undegraded RNA were loaded (data not shown).
Biochemical activity of the exogenous LDLR was assessed in situ by visualizing the uptake of Dil-LDL. Representative fluorescent micrographs are presented in Fig. 2 g-l. Mockinfected NZW rabbits exhibited a uniformly high level of fluorescence in all cells (Fig. 2g) , whereas mock-infected WHHL hepatocytes showed very little fluorescence (Fig. 2h) . WHHL hepatocytes infected with the LTR-LDLR virus had the greatest amount of LDL uptake with =20% of the cells showing high levels of fluorescence (Fig. 20 . BA-LDLRinfected WHHL hepatocytes demonstrated a population of cells with moderate activity (Fig. 2t) , whereas H4-LDLRinfected WHHL hepatocytes showed a low level of activity in virtually all cells (Fig. 2j) ; the activity of LDLR in TK-LDLRinfected cells was barely over background (Fig. 2k) .
Transduced hepatocytes were also analyzed for degradation of 125I-LDL in an attempt to quantify the amount of human LDLR expressed ( (10) , and the corresponding normal gene (i.e., for LDLR) has been cloned (30) . Second, correction of the metabolic consequences of the defect will most likely necessitate the transfer of a functional gene into hepatocytes (11) rather than the other more easily transplanted somatic cells. Finally, the WHHL rabbit appears to be an authentic animal model for familial hypercholesterolemia, a life-threatening human disease (7, (9) (10) (11) Having demonstrated efficient transfer and expression of the LDLR gene in WHHL hepatocytes in vitro, the next, more difficult step will be to transplant transduced hepatocytes into recipient WHHL rabbits in a way that they function and persist. Previously described methods for hepatocyte transplantation such as intrasplenic transplantation (31) and intraperitoneal transplantation of microcarrierattached hepatocytes (3) may be attempted with transduced WHHL hepatocytes. However, improved methods of hepatocyte transplantation will have to be developed before this approach could provide a long-term genetic cure of inherited diseases such as familial hypercholesterolemia. The development of methods for directly delivering the functional gene to hepatocytes in vivo may, in the long run, provide a more effective and less morbid approach to the genetic treatment of liver-specific inborn errors of metabolism.
